Literature DB >> 10754211

Preventive effect of epicatechin and ginsenoside Rb(2) on the inhibition of gap junctional intercellular communication by TPA and H(2)O(2).

K S Kang1, B C Kang, B J Lee, J H Che, G X Li, J E Trosko, Y S Lee.   

Abstract

The anticarcinogenic effects of epicatechin (EC) and ginsenoside Rb(2) (Rb(2)), which are major components of green tea and Korea ginseng, respectively, were investigated using a model system of gap junctional intercellular communication (GJIC) in WB-F344 rat liver epithelial cells. 12-O-tetradecanoylphorbol-13-acetate (TPA) and hydrogen peroxide, known as cancer promoters, inhibited GJIC in the epithelial cells as determined by the scrape loading/dye transfer assay, fluorescence redistribution assay after photobleaching, and immunofluorescent staining of connexin 43 using a laser confocal microscope. The inhibition of GJIC by TPA and H(2)O(2) was prevented with treatment of Rb(2) or EC. The effect of EC on GJIC was stronger in TPA-treated cells than in H(2)O(2)-treated cells, while the effect of Rb(2) was opposite to that of EC. EC, at the concentration of 27.8 microg/ml, prevented the TPA-induced GJIC inhibition by about 60%. Rb(2,) at the concentration of 277 microg/ml, recovered the H(2)O(2)-induced GJIC inhibition by about 60%. These results suggest that Rb(2) and EC may prevent human cancers by preventing the down-regulation of GJIC during the cancer promotion phase and that the anticancer effect of green tea and Korea ginseng may come from the major respective components, EC and Rb(2).

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10754211     DOI: 10.1016/s0304-3835(99)00438-3

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  9 in total

1.  Drinking green tea modestly reduces breast cancer risk.

Authors:  Martha J Shrubsole; Wei Lu; Zhi Chen; Xiao Ou Shu; Ying Zheng; Qi Dai; Qiuyin Cai; Kai Gu; Zhi Xian Ruan; Yu-Tang Gao; Wei Zheng
Journal:  J Nutr       Date:  2008-12-11       Impact factor: 4.798

2.  Fucoidan induces G1 phase arrest and apoptosis through caspases-dependent pathway and ROS induction in human breast cancer MCF-7 cells.

Authors:  Amal M Banafa; Sadia Roshan; Yun-Yi Liu; Hui-Jie Chen; Ming-Jie Chen; Guang-Xiao Yang; Guang-Yuan He
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2013-10-20

3.  Gap junction intercellular communication mediated by connexin43 in astrocytes is essential for their resistance to oxidative stress.

Authors:  Hoa T Le; Wun Chey Sin; Shannon Lozinsky; John Bechberger; José Luis Vega; Xu Qiu Guo; Juan C Sáez; Christian C Naus
Journal:  J Biol Chem       Date:  2013-12-03       Impact factor: 5.157

Review 4.  Ginseng for Liver Injury: Friend or Foe?

Authors:  Tae-Woo Kim
Journal:  Medicines (Basel)       Date:  2016-12-17

Review 5.  Role of ROS/RNS in Preeclampsia: Are Connexins the Missing Piece?

Authors:  María F Rozas-Villanueva; Paola Casanello; Mauricio A Retamal
Journal:  Int J Mol Sci       Date:  2020-06-30       Impact factor: 5.923

6.  Simultaneous quantification of six nonpolar ginsenosides in white ginseng by reverse-phase high-performance liquid chromatography coupled with integrated pulsed amperometric detection.

Authors:  Hyeyoung Song; Kyung-Won Song; Seon-Pyo Hong
Journal:  J Ginseng Res       Date:  2019-07-26       Impact factor: 6.060

Review 7.  Catechins and Their Therapeutic Benefits to Inflammatory Bowel Disease.

Authors:  Fei-Yan Fan; Li-Xuan Sang; Min Jiang
Journal:  Molecules       Date:  2017-03-19       Impact factor: 4.411

8.  Epicatechin used in the treatment of intestinal inflammatory disease: an analysis by experimental models.

Authors:  Paulo César de Paula Vasconcelos; Leonardo Noboru Seito; Luiz Cláudio Di Stasi; Clélia Akiko Hiruma-Lima; Cláudia Helena Pellizzon
Journal:  Evid Based Complement Alternat Med       Date:  2012-12-30       Impact factor: 2.629

Review 9.  Anticancer Activities of Protopanaxadiol- and Protopanaxatriol-Type Ginsenosides and Their Metabolites.

Authors:  Xiao-Jia Chen; Xiao-Jing Zhang; Yan-Mei Shui; Jian-Bo Wan; Jian-Li Gao
Journal:  Evid Based Complement Alternat Med       Date:  2016-06-30       Impact factor: 2.629

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.